Complegen Inc Headquarters
Looking for information about Complegen Inc Headquarters? The links below have collected all the necessary data.
CompleGen
- http://www.complegen.com/
- Welcome to CompleGen. We are an early stage biopharmaceutical company that is applying a proprietary system to discover novel biologically active chemicals.Our system is used to build compound discovery systems for a broad range of therapeutic targets for the pharmaceutical industry, as well as efficient cost-effective product discovery systems ...
CompleGen - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/complegen
- Legal Name CompleGen, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 206-447-9014. CompleGen is an early-stage biopharmaceutical company that is applying a proprietary system to discover novel biologically active chemicals.Their system is used to build compound discovery systems for a broad range of therapeutic ...
Complegen Inc LinkedIn
- https://www.linkedin.com/company/complegen-inc
- Complegen Inc 32 followers on LinkedIn. Complegen Inc is a biotechnology company based out of 1124 Columbia St # 662, Seattle, Washington, United States.
COMPLEGEN, INC. SBIR.gov
- https://www.sbir.gov/sbirsearch/detail/130437
- DESCRIPTION (provided by applicant): The goal of this project is to apply a novel, well developed cost effective means of drug target and drug discovery to parasitic disease, focusing on Trypanosoma c ...
CompleGen
- http://complegen.com/secCorporate.htm
- CompleGen is a drug discovery company applying novel genetic technology that makes the discovery of biologically active compounds such as drugs or agricultural products more efficient. Our XenoGene™ system can drastically speed the discovery of compounds that specifically act on a given target and not on others. (A target is a molecule ...
Have you found Complegen Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.